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OSCAR is a collagen receptor. (A) Binding of human Ig-like receptor Fc fusions to BSA or collagens I–V in a solid-phase binding assay (see 
Methods). A GpVI Fc-fusion protein (GpVI-Fc) was used as positive control for collagen-binding activity, and human IgG (hIgG) was used as neg-
ative control. For a description of the other human Ig-like receptor Fc-fusion negative controls, please see Methods and Supplemental Figure 2A. 
(B) hOSCAR-Fc, preincubated with murine IgG1 or anti-hOSCAR mAb 11.1CN5, binding to BSA or collagen I–III. Solid-phase assay binding 
data are represented as mean (n = 3) ± SEM. (C) Collagen I–FITC binds to hOSCAR-expressing RBL-2H3 cells (clone 9). RBL-2H3 cells stably 
expressing hOSCAR-FLAG (white) and untransfected RBL-2H3 cells (dark gray) were stained with FITC-conjugated anti-FLAG mAb and ana-
lyzed by flow cytometry. Collagen I–FITC binding to hOSCAR-FLAG transfected RBL-2H3 cells compared with that of untransfected-RBL-2H3 
cells. Preincubation with mouse anti-hOSCAR mAb 11.1CN5, but not a mouse IgG1 isotype control mAb, blocks collagen I–FITC binding to 
hOSCAR-FLAG expressing RBL-2H3 cells. (D) An OSCAR ligand is associated with OBs and stromal cells. Murine OSCAR-Fc (mOSCAR-Fc) 
and hOSCAR-Fc binding to collagenase-treated (white) or untreated (gray) BMSs or OBs.
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and hOSCAR-Fc,  as  assessed by  immunostaining  (Figure 1D). 
These results show that OSCAR binds to collagens I–III in vitro and 
to collagens associated with OB lineage or stromal cells.












































































Collagens are exposed to preosteoclasts at bone-remodeling sites. (A) 
OSCAR (red) is specifically localized in mononuclear cells expressing 
TRAP (black) on bone surfaces (light blue counterstain). (B) Mono-
nuclear OSCAR+ cells (red) in contact with collagen III (brown) and (C) 
collagen I (brown) at bone-remodeling sites. (D) Multinucleated TRAP+ 
cells express OSCAR, which (E) is also located in contact with collagen I 
at the bone surface. Note the 2 situations in which collagen I and III 
make contacts with OSCAR+ cells: (a) located below OSCAR+ cells, 
exposed on bone surfaces (asterisks), and also (b) above OSCAR+ 
cells, associated with bone-lining cells (arrows) at bone-remodeling 
sites. The localization of each antigen was validated with 2 indepen-
dent antibodies. Scale bar: 10 μm.
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OSCAR recognition of its collagen motif costimulates osteoclastogenesis 













OSCAR binds to a specific triple-helical motif in collagen. (A) hOSCAR-Fc binding (y axis, OD 450 nM) to overlapping triple-helical peptides 
(x axis) from the collagen II and III Toolkits (29, 30). (B) Alignment of triple-helical collagen peptide sequences from Toolkits II and III, displaying 
highest affinity for hOSCAR-Fc. Predicted hOSCAR collagen-binding consensus is denoted by underlining. Alignment anchor residues are in 
red. (C) hOSCAR-Fc binding to triple-helical III-36 peptide “halves,” trimmed consensus (underlined), and effect of Alanine scan (bold) through 
variable X and X′ residues. (D) Effect of various amino acid substitutions through the variable X and X′ residues of the III-36 triple-helical peptide 
backbone and deletion of the C-terminal triplet on hOSCAR-Fc binding. These data indicate that GPOGPX′GFX, where each proline residue 
can be substituted by Alanine, is a preferred generic OSCAR-binding motif. Other permissive substitutions remain to be defined. (E) “Minimum” 
collagen-binding consensus, with alignment of variant hOSCAR-binding residues. Data are represented as mean (n = 3) ± SEM.
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The triple-helical conformation of the OSCAR-binding motif in collagen ligands can induce OSCAR signaling. (A) Dot plots (2,000 events) display-
ing the response of a hOSCAR-CD3ζ NFAT-GFP reporter cell line to immobilized BSA, (GPP)10, (GPP)5-GLOGPSGEO-(GPP)5, (GPP)5-GPOG-
PAGFOGAO-(GPP)5, or (GPP)5-GAOGPAGFA-(GPP)5 or collagens I–V (y axis, GFP expression; x axis, forward scatter). (B) Dot plots (10,000 
events) displaying the responses (GFP expression) of the hOSCAR-CD3ζ and murine OSCAR-CD3ζ (mOSCAR-CD3ζ) NFAT-GFP reporter cell 
lines to immobilized BSA; a linear peptide containing the minimal OSCAR-binding sequence GPOGPAGFO (linear); or a triple-helical peptide 
designed to the minimal OSCAR-binding sequence, (GPP)5-GPOGPAGFO-(GPP)5 (peptide sequences can be found in Supplemental Table 1) 
(y axis, GFP expression; x axis, forward scatter). (C) Calcium spikes per cell per 10-minute period for human monocytes cultured on either immo-
bilized OSCpep or (GPP)10. Data are represented as mean (n = 5) ± SEM; *P < 0.05. (D) Representative calcium traces for human monocytes 
cultured on either immobilized OSCpep or (GPP)10.
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The OSCAR collagen-binding motif costimulates osteoclastogenesis from human monocytes. (A) Day 6 RANKL differentiation of human monocytes 
on the plate-immobilized OSCpep, (GPP)5-GPOGPAGFOGAO-(GPP)5, or (GPP)5-GAOGPAGFA-(GPP)5, or the control protein BSA, or the con-
trol peptides OVA or (GPP)10 or (GPP)5-GLOGPSGEO-(GPP)5. Data are represented as mean (n = 3) ± SEM; *P < 0.05 indicates an increase 
in osteoclasts cultured on OSCpep compared with other culture conditions. (B) TRAP staining of day 6 human osteoclast cultures. Scale bar: 
70 μM. (C) Anti-hOSCAR mAb 11.1CN5, but not IgG1, inhibits osteoclastogenesis on immobilized OSCpep, showing the costimulatory action of 
OSCpep on osteoclastogenesis is hOSCAR specific. Data are represented as mean (n = 3) ± SEM; *P < 0.05.
Downloaded from http://www.jci.org on January 16, 2017.   https://doi.org/10.1172/JCI45913
research article


































The OSCAR collagen-binding motif costimulates murine osteoclastogenesis. (A) RANKL differentiation of wild-type, Oscar–/–, or Fcer1g–/– BMMs 
cultured on either immobilized OSCpep or control proteins at 30 ng/ml RANKL or (B) 100 ng/ml RANKL. Data are represented as mean (n = 3) ± SEM; 
*P < 0.05 indicates an increase in osteoclasts cultured on OSCpep compared with all other culture conditions and genotypes. The number 
of nuclei (e.g., 3–10, 11–40, or >40) per TRAP+ osteoclast (OC), as well as the total number of osteoclasts, was enumerated for each well 
(x axis). (C) Quantitative RT-PCR expression of osteoclast genes from day 5 osteoclast cultures (black bars, wild type; white bars, Oscar–/–). 
Data are normalized relative to GAPDH and represented as mean (n = 3) ± SEM; *P < 0.05.  
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The effects of TGF-β1 and immobilized OSCpep on osteoclastogenesis are additive. (A) Effect of ±0.1 ng/ml TGF-β1 on the osteoclastogenesis 
of wild-type or Oscar–/– BMMs cultured on either immobilized BSA or OSCpep at 10 ng/ml RANKL or (B) 30 ng/ml RANKL. The number of nuclei 
(e.g., 3–10, 11–40, or >40) per TRAP+ osteoclast, as well as the total number of osteoclasts, was enumerated for each well (x axis). Data are 
represented as mean (n = 3) ± SEM; *P < 0.05 indicates an increase in osteoclasts cultured on OSCpep plus TGF-β1 compared with either BSA 
with or without TGF-β1 or OSCpep alone.
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OSCAR recognition of the collagen motif costimulates osteoclastogenesis of precursors from DAP12–/– mice and TREM-2– and DAP12-deficient 
patients with NH. (A) Immobilized OSCpep rescued the osteoclastogenesis of murine DAP12–/– BMMs (day 6) compared with that of wild-type 
(day 5). (B) TRAP staining (scale bar: 70 μM), (C) DAPI (blue fluorescence), and Phalloidin–Alexa Fluor 488 (green) staining of OSCpep-rescued 
giant multinucleated DAP12–/– cells (scale bar: 60 μM). (D) Retroviral transduction of mouse OSCAR, long-signal peptide isoform (SP-L), rescued 
osteoclastogenesis of DAP12–/–Oscar–/– preosteoclasts, showing that the costimulatory signaling and rescue of osteoclastogenesis is OSCAR 
specific. (E) Effect of immobilized proteins and peptides on osteoclastogenesis of TREM-2–deficient (day 14) or (F) DAP12-deficient monocytes 
from patients with NH (day 10). (G) TRAP staining of RANKL-differentiated NH monocytes in wells coated with different proteins and peptides 
(scale bar: 70 μM). Data are represented as mean (n = 3) ± SEM.
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OSCAR costimulates a major DAP12-
independent pathway for osteoclasto-
genesis in vivo. (A) Histology (TRAP, 
toluidine blue, and von Kossa staining) 
of the tibia (metaphysis) from DAP12–/–
Oscar–/– (DKO) and DAP12–/– mice (scale 
bar: 100 μM). The bone marrow cavity of 
DAP12–/–Oscar–/– mice is reduced (tolu-
idine blue staining) and filled with more 
unresorbed bone (von Kossa) compared 
with that of DAP12–/– mice. (B) Decrease 
in TRAP+ osteoclast numbers (osteo-
clast number/bone surface/mm [N.Oc/
BS/mm]), (C) osteoclast size (osteoclast 
surface/bone surface [Oc.S/BS] [%]), and 
(D) eroded bone surfaces (eroded sur-
face/bone surface [ES/BS]), with a con-
comitant increase in (E) trabecular bone 
volume (bone volume/tissue volume 
[BV/TV]) in DAP12–/–Oscar–/– mice com-
pared with those in DAP12–/– mice. Data 
are represented as mean (n = 10) ± SEM; 
*P < 0.05.
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